diphenyliodonium has been researched along with nitroglycerin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Freeman, BA; Harrison, DG; Münzel, T; Sayegh, H; Tarpey, MM | 1 |
| Agarwal, R; Kaminski, PM; Mohazzab-H, KM; Wolin, MS | 1 |
2 other study(ies) available for diphenyliodonium and nitroglycerin
| Article | Year |
|---|---|
Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance.
Topics: Acetylcholine; Animals; Aorta; Biphenyl Compounds; Colforsin; Dose-Response Relationship, Drug; Drug Tolerance; Endothelium, Vascular; Female; In Vitro Techniques; Liposomes; Male; Molsidomine; Nitro Compounds; Nitroglycerin; Onium Compounds; Rabbits; Superoxide Dismutase; Superoxides; Vasodilation; Vasodilator Agents | 1995 |
Potential role of a membrane-bound NADH oxidoreductase in nitric oxide release and arterial relaxation to nitroprusside.
Topics: Animals; Biphenyl Compounds; Cattle; Ferricyanides; Free Radical Scavengers; Guanylate Cyclase; Membranes; NADH, NADPH Oxidoreductases; Nitric Oxide; Nitroblue Tetrazolium; Nitroglycerin; Nitroprusside; Onium Compounds; Oxidation-Reduction; Pulmonary Artery; Vasodilator Agents | 1999 |